𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

✍ Scribed by Strathdee, G; MacKean, M J; Illand, M; Brown, R

Book ID
110061984
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
387 KB
Volume
18
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Role of hMLH1 promoter hypermethylation
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
✍ Christian N. Arnold; Ajay Goel; C. Richard Boland πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 432 KB πŸ‘ 1 views

## Abstract Loss of DNA mismatch repair (MMR) occurs in 10–15% of sporadic colorectal cancer, is usually caused by hMLH1 hypermethylation, and has been shown to confer resistance to various chemotherapeutic reagents, including 5‐fluorouracil (5‐FU). We tested the hypothesis that demethylation of th

Methylation of the hMLH1 promoter in fam
Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability
✍ Yuka Yanagisawa; Yoshimitsu Akiyama; Satoru Iida; Emi Ito; Tadashi Nomizu; Kenic πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 128 KB πŸ‘ 2 views

Microsatellite instability (MSI), which is recognized as an important mechanism in tumorigenesis, has been reported in familial gastric cancers (FGC). However, genetic defects responsible for this phenotype, that is, mutations in mismatchrepair genes such as hMLH1 and hMSH2, have not been detected i